These aforementioned longitudinal and prospective findings add to the evidence of a cross‐sectional study published by our group, by validating the robust correlation between systemic inflammation and NfL serum levels in patients with cirrhosis [9]. The gene discussed is NEFL; the disease is Cirrhosis.